Related Experiment Video
Updated: Aug 12, 2025

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
Ablative Margins of Colorectal Liver Metastases Using Deformable CT Image Registration and Autosegmentation
Yuan-Mao Lin1, Iwan Paolucci1, Caleb S O'Connor1
1From the Departments of Interventional Radiology (Y.M.L., I.P., B.C.O.), Imaging Physics (C.S.O., B.M.A., B.R., K.A.J., K.K.B.), and Biostatistics (B.M.F.), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
A new deformable image registration method accurately quantifies the minimal ablative margin (MAM) after colorectal liver metastasis (CLM) ablation. An MAM of 5 mm or greater is optimal for preventing local disease progression.
Area of Science:
- Radiology
- Medical Imaging
- Oncology
Background:
- Confirming complete ablation with adequate margins is crucial for local tumor control in colorectal liver metastasis (CLM) ablation.
- Current image-based methods lack consideration for patient and ablation-related biomechanical deformation, creating an unmet need.
- Accurate assessment of the minimal ablative margin (MAM) is essential for predicting treatment outcomes.
Purpose of the Study:
- To evaluate a biomechanical deformable image registration (DIR) method for quantifying the 3D minimal ablative margin (MAM) after CT-guided CLM ablation.
- To assess the association between MAM and local disease progression following CLM ablation.
- To spatially localize sites of local disease progression relative to the ablation zone.
Main Methods:
- Retrospective analysis of 213 CLMs in 124 patients treated with CT-guided ablation.
- Application of a biomechanical DIR method with AI-based autosegmentation for MAM quantification.
- Multivariable Fine-Gray subdistribution hazard model used to evaluate factors associated with local disease progression.
Main Results:
- A minimal ablative margin (MAM) of 0 mm was associated with a 72% 2-year local disease progression rate.
- An MAM between 0 and 5 mm had a 12% 2-year local disease progression rate.
- No local disease progression was observed with an MAM of 5 mm or greater; MAM of 0 mm was independently associated with local disease progression (SHR, 23.3).
Conclusions:
- Biomechanical DIR and AI autosegmentation enable effective identification and spatial localization of CLMs at risk for local progression post-ablation.
- A minimal ablative margin (MAM) of 5 mm or greater is identified as the optimal endpoint for preventing local disease progression.
- This method provides crucial insights for improving local tumor control strategies in CLM ablation.
More Related Videos
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018